Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
When combining two different medications, such as NSAIDs and semaglutide, understanding the potential risks is essential for safe use
How do I get started with a GLP-1 program in Las Vegas
However, a growing number of reports suggest that these side effects can cause gastroparesis for some users, slowing gastric emptying to the extent that it results in stomach paralysis
Common and Severe Side Effects of Compounded Tirzepatide Like any medication, side effects of Tirzepatide should be carefully considered
Starting early means your skin is actively tightening Collagen production takes time
.png)
